SUBSCRIBE
SUBSCRIBE
News   FDA

AMAG Pharmaceuticals, Inc. Gets FDA Request for More Data on Anemia Drug

October 20, 2008 | 
1 min read

CAMBRIDGE, Mass. - Biotechnology company AMAG Pharmaceuticals Inc. said Monday the Food and Drug Administration wants more information on a prospective anemia drug before considering it for approval.

FDA Approvals Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Facade of the FDA's office in Maryland
Policy
RFK Jr. Eyes Changes to Vaccines Injury Surveillance System to Deduce ‘Culprit’
April 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Diverse cultures, international communication concept. Human silhouette with speech bubbles.
Regulatory
Former FDA Officials Sound Alarm: Visible Changes May Be ‘Tip of the Iceberg’
April 16, 2025
 · 
3 min read
 · 
Heather McKenzie
Podcast
Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed
April 16, 2025
 · 
1 min read
 · 
Heather McKenzie
Flat lay composition with sleep eye mask, dream book and alarm clock on dark blue background. Healthy sleeping concept.
Legal
Vanda Sues FDA Again, This Time Over Off-Label Use of Hetlioz for Jet Lag
April 14, 2025
 · 
2 min read
 · 
Tristan Manalac